New Study Details High Rates of Rehospitalizations, Emergency Pain Treatment of Sickle Cell Disease

Summary


"This study is important because it provides benchmark data to evaluate the quality of management of sickle cell disease symptoms," said AHRQ director Carolyn M. Clancy, M.D. "The next step is to determine why patients are being rehospitalized or seeking emergency department treatment at this rate and to make improvements in their care."

"It was important for us to draw attention to the high rate of acute care utilization ior people with sickle cell disease. Armed with this knowledge, we can focus attention on the need for improved care for people with sickle cell disease," said lead study author David C. Brousseau, M.D., M.S., associate professor of pediatrics at the Medical College of Wisconsin. He also practices at Children's Hospital of Wisconsin as a pediatric emergency specialist.

The largest study to date of the use of acute care medical services by people with sickle cell disease found four of every 10 had to return to the hospital within 30 days of a previous hospitalizatton or go to the emergency department for treatment of pain, according to a new study funded in part by HHS' Agency for Healthcare Research and Quality.

See the full content of this document

Extract


New Study Details High Rates of Rehospitalizations, Emergency Pain Treatment of Sickle Cell Disease

The largest study to date of the use of acute care medical services by people with sickle cell disease found four of every 10 had to return to the hospital within 30 days of a previ...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company